CDMO - August 10, 2021
Recipharm signs Memorandum of Understanding in Morocco
Recipharm, has signed an Memorandum of Understanding (MOU) for the fill finish of vaccines and biotherapeutics in Morocco. Recipharm has signed the MOU, along with His Majesty the King of Morocco, the Moroccan government and a consortium of the country’s leading banks, that will see the company operate a new fill finish factory in Morocco. […]
CDMO - April 7, 2021
She is the winner of Recipharm’s International Environmental Award
CDMO Recipharm has announced that its 2020 International Environmental Award will be presented to Amy Pruden, Professor of Civil and Environmental Engineering at Virginia Tech in Blacksburg, Virginia, US. Amy Pruden is widely recognized for her work documenting antibiotic resistance genes as environmental contaminants, says Recipharm in a press release. Her most recent research focuses […]
CDMO - February 4, 2021
Recipharm and Medspray launch joint venture
Recipharm and Medspray have completed a previously announced joint venture and established Resyca BV. Resyca will develop and exploit the softmist spray nozzle technology for pharmaceutical applications. This has the potential to eliminate the need for propellants by delivering therapies deep into the lungs more effectively with lower doses as less ends up in the […]
Agreement - January 20, 2021
Recipharm signs manufacturing agreement with Enzymatica
Recipharm and Enzymatica have signed a broadened contract for the manufacture of ColdZyme. The agreement will involve an additional Recipharm production site in Pianezza, Italy, to support Enzymatica in increasing production volumes of ColdZyme to meet growing global demand. Both the facilities in Parets, Spain, and Pianezza, Italy, will be making additional investments to accommodate […]
Acquisition - January 15, 2021
EQT announces a public offer to the shareholders of Recipharm
In December 2020, EQT IX, through Roar BidCo AB, announced a public offer of SEK 220 in cash per share to the shareholders of Recipharm AB and SEK 1,427,010 in cash per Convertible Bond. The class B shares in Recipharm are listed on Nasdaq Stockholm, Mid Cap. The Convertible Bonds are admitted to trading on […]
COVID-19 - January 10, 2021
Production and supply – A logistics challenge
The manufacturing, packaging and transportation of COVID-19 vaccines requires a smooth, effective and safe supply chain. Time is of the essence, and the pharma industry supply chain is facing big logistics challenges. In record time the global life science industry has been able to discover and develop one vaccine approved for full use, six vaccines […]
